Pneumococcal infection in adults: burden of disease
Top Cited Papers
Open Access
- 1 May 2014
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 20 (s5), 45-51
- https://doi.org/10.1111/1469-0691.12461
Abstract
To overview the present global burden of pneumococcal disease is important because new preventive measures such as the pneumococcal conjugate vaccine 13 are currently being evaluated. Pneumococcal disease is roughly divided into non-invasive and invasive disease. The burden of non-invasive pneumococcal disease in adults is mainly determined by community-acquired pneumonia. Pneumococcal pneumonia has high incidence rates and carries a high mortality risk, especially in the elderly. Within the cluster of invasive pneumococcal diseases, pneumonia also represents the most common infectious source. Incidence and mortality rates of both non-invasive and invasive disease have changed as a result of pneumococcal vaccination in children. However, especially elderly patients with comorbidities remain vulnerable to morbidity and mortality caused by pneumococcal disease. The current review summarizes the current knowledge on the epidemiology including outcome of the main clinical forms of pneumococcal disease, with a special focus on elderly patients. Furthermore, the economic burden and future vaccine strategies are briefly discussedKeywords
This publication has 72 references indexed in Scilit:
- Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based studyBMC Infectious Diseases, 2013
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic TechniquesPLOS ONE, 2013
- Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)BMC Infectious Diseases, 2012
- Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumoniaEpidemiology and Infection, 2012
- Pneumococcal Conjugate Vaccine for Adults: A New ParadigmClinical Infectious Diseases, 2012
- Trends in Mortality and Medical Spending in Patients Hospitalized for Community-Acquired PneumoniaMedical Care, 2010
- Ageing populations: the challenges aheadThe Lancet, 2009
- New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare qualityThorax, 2009
- Decreases in Case‐Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995–2007: A Population‐Based StudyClinical Infectious Diseases, 2008
- Biology of Immune Responses to Vaccines in Elderly PersonsClinical Infectious Diseases, 2008